McKesson Corporation (FRA:MCK)

Market Cap	98.51B +33.2%
Revenue (ttm)	338.94B +15.5%
Net Income	3.70B +53.6%
EPS	29.59 +59.2%
Shares Out	n/a
PE Ratio	26.65
Forward PE	22.07
Dividend	2.72 (0.34%)
Ex-Dividend Date	Dec 1, 2025

Volume	n/a
Average Volume	3
Open	791.60
Previous Close	813.00
Day's Range	791.60 - 791.60
52-Week Range	562.00 - 816.00
Beta	n/a
RSI	59.36
Earnings Date	Feb 4, 2026

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1833
• Employees: 45,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MCK

Financial Performance

In fiscal year 2025, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD